Literature DB >> 8633573

Premalignant and early malignant lesions in the gastrointestinal tract: definitions, terminology, and problems.

R H Riddell1.   

Abstract

The definition of a "premalignant" lesion is discussed, together with its relationship to dysplastic change. The definition and description of dysplasia are given. Systems for grading dysplasia are set out, and the clinical implications of these changes are discussed. Although the "dysplasia terminology" in current use remains the gold standard for clinical practice, a series of more recent developments, including the discovery of flat and depressed adenomas, the possibility of de novo carcinoma throughout the gastrointestinal tract, as well as advances in molecular biology, raise the question of whether this terminology will be adequate in future. Other terminologies exist that provide an alternative viewpoint, but none is satisfactory.

Entities:  

Mesh:

Year:  1996        PMID: 8633573

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

1.  Diagnosis of gastric epithelial neoplasia: Dilemma for Korean pathologists.

Authors:  Joon Mee Kim; Mee-Yon Cho; Jin Hee Sohn; Dae Young Kang; Cheol Keun Park; Woo Ho Kim; So-Young Jin; Kyoung Mee Kim; Hee Kyung Chang; Eunsil Yu; Eun Sun Jung; Mee Soo Chang; Jong Eun Joo; Mee Joo; Youn Wha Kim; Do Youn Park; Yun Kyung Kang; Sun Hoo Park; Hye Seung Han; Young Bae Kim; Ho Sung Park; Yang Seok Chae; Kye Won Kwon; Hee Jin Chang
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

2.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

3.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

4.  The long term outcome of gastric non-invasive neoplasia.

Authors:  M Rugge; M Cassaro; F Di Mario; G Leo; G Leandro; V M Russo; G Pennelli; F Farinati
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

5.  Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP.

Authors:  Nicole Nemetz; Catalina Abad; Greg Lawson; Hiroko Nobuta; Seririthanar Chhith; Lucy Duong; Gary Tse; Jonathan Braun; James A Waschek
Journal:  Int J Cancer       Date:  2008-04-15       Impact factor: 7.396

Review 6.  Inflammatory bowel disease associated neoplasia: A surgeon's perspective.

Authors:  Azah A Althumairi; Mark G Lazarev; Susan L Gearhart
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 7.  Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines.

Authors:  Vicent Hernández; Juan Clofent
Journal:  Ann Gastroenterol       Date:  2012

8.  Expression of costimulatory molecule CD80 in colonic dysplasia in ulcerative colitis: an immunosurveillance mechanism against colorectal cancer?

Authors:  Marco Scarpa; Roubik Behboo; Imerio Angriman; Attilio Cecchetto; Renata D'Incà; Barbara Termini; Michela Barollo; Cesare Ruffolo; Lino Polese; Giacomo Carlo Sturniolo; Davide Francesco D'Amico
Journal:  Int J Colorectal Dis       Date:  2006-03-07       Impact factor: 2.796

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.